Interpreting | 2014.03.13
MEDIAN Technologies Signs a €700K Contract with a Top Five Pharmaceutical Company
SOPHIA ANTIPOLIS, France--(BUSINESS WIRE)--Regulatory News: MEDIAN Technologies (Paris:ALMDT), a leading medical imaging software solutions developer and a service provider for image interpretation and management in oncology clinical trials, today announced it has signed a contract with a global top five pharmaceutical company. Within the framework of this contract, MEDIAN will provide imaging services in a large phase I/II clinical trial. The contract amount is approximately €700K (eq. $ 960,0
For more information, please visit
http://www.businesswire.com/news/home/20[...]0K-Contract-Top-Pharmaceutical
